The Short Seller’s Argument Nobody Wants You to Hear on Mega IPOs
Mega AI IPOs are lining up with trillion-dollar aspirations, but a contrarian view warns that upside may hinge on elu...
This comparison highlights how zero-based and monthly budgeting differ, plus tips to choose and implement the best method for you.
20,116 articlesMega AI IPOs are lining up with trillion-dollar aspirations, but a contrarian view warns that upside may hinge on elu...
A bipartisan bill would establish a Federal Cryptocurrency Theft Task Force within the DOJ, aiming to coordinate pros...
A six-year Wharton study links leader narcissism to resistance to remote work. The research suggests Fortune 500 boss...
A robotics wave is reshaping American productivity, with big investments and bold forecasts. Yet policy, skills, and ...
A thoughtful tribute to a public figure whose approach to tax policy blends discipline with cooperation. This piece p...
Meta enters paid AI services with Muse Spark 1.1, pricing the frontier model far below rivals and signaling a major p...
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A Capitol Hill hearing put Meta under sharp scrutiny over its teen and tween targeting. Lawmakers demanded tighter sa...
AI's rapid growth in 2026 is real, but the panic around job loss and market collapse is overblown. This report explai...
A Middle East conflict is reviving centuries-old trade ideas and testing the WTO framework, with ripple effects on en...
A Sydney-based tech founder uses AI to design a bespoke cancer vaccine for his dog, Rosie, signaling a new frontier i...
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...